Drug profile · INN
etanercept
BENEPALI
- US status
- approved
- Patents linked
- 8
- News articles
- 1
Quick answer
etanercept (BENEPALI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11419812
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11135267
Etanercept formulations stabilized with metal ions
granted -
US 11129876
Etanercept formulations stabilized with amino acids
granted -
US 11001627
Correctly folded etanercept in high purity and excellent yield
granted -
US 11000588
Etanercept formulations stabilized with sodium chloride
granted -
US 10987405
Method of reducing formation of etanercept aggregates or fragments
granted -
US 10980884
Stable aqueous etanercept composition
granted -
US 10980885
Method of reducing formation of etanercept aggregates or fragments
granted
Frequently asked questions
What is etanercept?
etanercept (BENEPALI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for etanercept?
BENEPALI is a marketed brand name for etanercept. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of etanercept?
etanercept has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.